Insmed, Inc. vs Johnson & Johnson
INSM vs JNJ — side-by-side comparison from reported financials. INSM leads 2, JNJ leads 4 of 6 comparable metrics.
Insmed, Inc.
INSM · Healthcare
$100.50+0.02%Strained
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | INSM | JNJ |
|---|---|---|
| Price | $100.50 | $261.79 |
| Market cap | $21.9B | $631B |
| Revenue (TTM) | — | $97.9B |
| Revenue growth | +35.2% | +5.6% |
| Net margin | — | 21.5% |
| Free cash flow | -$808M | $22.2B |
| Net cash (debt) | $889M | ($27.8B) |
| 1-year price return | -38.9% | +37.0% |
| P/E | — | 29.9 |
| P/E vs own history (cheap-side %) | — | 16% |
| Dividend yield | — | 2.00% |
| Return on equity | -111% | 26% |
| CV checks passed | 3 of 9 | 10 of 9 |
| Employees | 1,664 | 140,800 |
Full résumé-style profiles: INSM CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.